SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ELI LILLY
(NYSE:LLY Last Sale: 153.28 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (LLY : $153.28)
$146,694,853 million Market Cap at Market Close, July 1, 2022
Employs 40,600.
Drugs SubIndustry up .00% / Health Industry up .00% Today
Lilly Corporate Center Research Report World View
Indianapolis, IN 46285 Fact Sheet Earnings Snapshot - Last 01/30/19
Phone: (317) 276-2000 Financial Statements
Fax: (317) 276-3492 Peer Comparison
Annual Reports

Sidney Taurel, Ex. Chmn., John C. Lechleiter, CEO/Pres., Derica W. Rice, CFO
Discovers, develops, manufactures & sells a line of human health & pharmaceutical products. Acquired APPLIED MOLECULAR EVOLUTION INC (Nasdaq:AMEV) February 11, 2004 for $18 in cash and stock per share. Acquired ICOS CORP (Q:ICOS) January 30, 2007 for $2.1 billion, $32 per share. Since 1998, Lilly and ICOS have been partners in Lilly ICOS LLC, the joint venture that manufactures Cialis.
Historical Charts    Technical Analysis
No Historical Data available for LLY

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common LLY $153.28 $153.28 0 .0 $151.26 $156 2,225,710 $151.26 $156 957,038,447
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############
Dividend Information
Annual Dividend Yield Earnings Payout

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
15-OCT-97 LLY Split 2 for 1
20-DEC-95 LLY Split 2 for 1

A4005
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex